Fundraising Fox
Temprian Therapeutics
Chicago, US · Founded 2019 · Delaware corporation · 3 employees on LinkedIn · 1 known investors
Find your way into Temprian Therapeutics
Sign up to see every warm intro you have to Temprian Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Temprian Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.
Founders & leadership
Temprian Therapeutics was founded in 2019 by Isabelle Caroline Le Poole and Caroline Le Poole.
IC
Isabelle Caroline Le PooleCo-founder
JN
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$275K disclosed across 1 round · 2019
▶$275KraisedNov 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$275KraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kettil CedercreutzExecutive Officer, Director
- Isabelle Caroline Le PooleExecutive Officer, Director
- Offering amount
- $325K
- Amount sold
- $275K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Temprian Therapeutics do?
- Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.
- Who founded Temprian Therapeutics?
- Temprian Therapeutics was founded by Isabelle Caroline Le Poole, Caroline Le Poole in 2019.
- Who are Temprian Therapeutics's investors?
- Temprian Therapeutics's investors include 2Flo Ventures.
- How much funding has Temprian Therapeutics raised?
- Temprian Therapeutics has disclosed $275K raised across 1 round.
- Where is Temprian Therapeutics headquartered?
- Temprian Therapeutics is headquartered in Chicago, US.